The pharmaceutical industry is greatly affected by policies, and policy adjustments will have a fundamental impact on various aspects of enterprise research and development, production, and sales. Therefore, the uncertainty brought about by industry policy adjustments is an important risk factor for the future development of companies.
After being reviewed and approved at the 2012 Annual Shareholders' Meeting held by the company on April 19, 2013, the company's profit distribution plan for 2012 is as follows: